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Claudio F Donner1* and Carlo Gulotta2In 1987 the first International Conference on the
Management of Chronic Respiratory Failure was held in
Veruno (Italy). Twenty five years and six Conferences
later much has changed, not only in regard to the
organization of the Conference itself (e.g., now it is held
every three years instead of five as originally), but also
the problems arising from chronic respiratory diseases
(CRDs) have changed. Today, according to World Health
Organisation’s (WHO) estimates, some 300 million
people worldwide suffer from asthma and 80 million
people are affected by moderate to severe COPD. These
diseases are among the most important causes of death
in our society and their burden is constantly increasing.
Over the last 20 years effective technical and pharmaco-
logical aids have been added to the tool-box of the chest
physician, improving the life of patients both in terms of
expectancy and quality. Obviously, this development of
chest medicine has also had important repercussions on
health resources consumption and currently there is a
widespread debate on how to cope with the growing
burden. The International Conference on “Management
and Rehabilitation of Chronic Respiratory Failure” - now
in its 7th edition - is recognized as a key international
scientific event in this specific field.
The 2012 “Pulmonary Advances”, which will be held
in Turin, will deal with new developments in respiratory
medicine as well as with their cost-effectiveness and the
best way to deliver them, with particular focus on the
possibilities of integration between specialists and pri-
mary care medicine. Two major scientific events will run
in parallel: the 7th International Conference and the 3rd
National Congress of AIMAR (Interdisciplinary Scientific
Association for Research in Lung Disease). The novel
idea underpinning AIMAR is that management of re-
spiratory diseases should not be solely in the hands of
the pneumologists but should be multidisciplinary. This
approach goes beyond the purely ‘organ specialist’ out-
look prevalent in clinical practice, integrating the diverse
professional figures (including non-medical health* Correspondence: cfdonner@mondomedico.it
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sional education, the development of joint clinical con-
trolled studies, epidemiological surveillance and public
health education in order to lay the foundations for an
optimal management of respiratory diseases. The Con-
ference/Congress of Turin 2012 will thus have a clear
interdisciplinary character, offering the maximum in
terms of quality, up-to-date information in the fight
against and prevention of CRDs. This is in harmony with
the scope of GARD (Global Alliance against Chronic Re-
spiratory Diseases), a WHO-based voluntary alliance of
national and international organizations aimed at im-
proving the respiratory health of the general population
by fighting the current problem of underdiagnosis and
undertreatment of CRDs. The benefit of this is very evi-
dent to professionals, health planners and decision
makers, but what benefit is there for the patient and
general public? There is nothing but to gain from a
greater flow of information between the various specia-
lists and a more integrated mode of clinical practice.
Patient management will no longer be - as it is often
today - the fruit of improvised collaboration, but it will
be based on a global, comprehensive model of care that
coordinates the up-to-date expertise of diverse specia-
lists. Moreover, assuring patients a homogeneous proto-
col of diagnosis and treatment irrespective of what
specialist branch they consult for a respiratory problem
will give them the added security of knowing they are
cared for by professionals who have a united vision of
their case. In short, AIMAR represents a great alliance
between physicians, health professionals and patients
for the lungs, which means a great alliance for the bene-
fit of all citizens. Our wish is that the commitment
manifested by the Scientific Committees and Organiz-
ing Committee - in their respective areas of competence
- combined with the work of the almost 200 speakers
and a fruitful exchange of opinions among participants
will enable us to realize that particular “mix” that will
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